ESC 365 - Use of riociguat as front-line therapy in a patient with high-risk pulmonary arterial hypertension and right ventricular failure.

ESC Professional Premium Access

Use of riociguat as front-line therapy in a patient with high-risk pulmonary arterial hypertension and right ventricular failure.

Session: Pulmonary hypertension (2)

Topic: Clinical

Speaker: Doctor J. Gamez Jimenez (Monterrey, MX)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Jose Daniel Gamez Jimenez

Unidad Medica de Alta Especialidad Hospital de Cardiologia No. 34 IMSS, Monterrey (Mexico)

1 presentation

0 follower

3 more presentations in this session

Role of cardiac magnetic resonance in the management of complex congenital heart diseases

Speaker: Doctor M. Abbate (Naples, IT)

Pulmonary arterial hypertension associated with double intracardiac shunt

Speaker: Doctor E. Palacios (Monterrey, MX)

Pulmonary veno-occlusive disease: getting the timing right for transplantation

Speaker: Doctor H. Nashat (London, GB)

Access the full session

Pulmonary hypertension (2)

Speakers: Doctor J. Gamez Jimenez, Doctor M. Abbate, Doctor E. Palacios, Doctor H. Nashat

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources